Research Study

ASCEND GO-2: Study of RVT-1401 for the Treatment of Patients With Active, Moderate to Severe Graves' Ophthalmopathy
Principal Investigator 
Peter J. Dolman

Overview

Body Locations and Systems 
Eye Disorders
ClinicalTrials.gov# 
NCT03938545
Status 
Recruiting
Study Start/End 
Feb 4, 2021
Name/Title 
Aleksandra Kuzmanovic, Research Coordinator
Phone 
604-875-4253
Purpose of Study 

The purpose of this study is to assess the efficacy and safety/tolerability of three dose regiments of RVT-1401 in the treatment of active, moderate to severe Graves' Ophthalmopathy.

Eligibility 

Visit ClinicalTrials.gov for more information.

Disclaimer 

Study Coordinators and Research Nurses cannot give medical advice over the phone. Telephone numbers and email addresses are provided for obtaining additional information on specific research studies only. If you have specific questions which require clinical expertise, please call your primary care physician.